Novartis (NVS)

Add to Watchlists
Create an Alert
84.67 +0.26  +0.31% NYSE Apr 17, 8:00PM BATS Real time Currency in USD

Novartis News

Edit Sources
Roche Meets Sales Estimates in Q1 - Analyst Blog
Zacks 04/17 16:00 ET

Sales of $13.0 billion were in line with the Zacks Consensus Estimate in the first quarter.

Does Pfizer Offer Good Value?
Yahoo 04/15 14:32 ET

Why ThromboGenics (TBGNF) Stock Is Higher Today
The Street 04/14 10:30 ET

Shares of ThromboGenics (TBGNF) are higher after Novartis (NOV) and Shire (SHPG) were said to be among drugmakers considering offers for the Belgian eye-medicine company.

Update on BioLineRx's BL-8040 - Analyst Blog
Zacks 04/11 18:10 ET

BioLineRx announced that Prof. Arnon Nagler was given the final regulatory approval to evaluate BL-8040 in a phase I/II study for the treatment of CML.

Balanced Risk-Reward for The Cooper Companies - Analyst Blog
Zacks 04/11 15:00 ET

We believe The Cooper Companies is poised for growth given its significant market share in high growth specialty lenses.

FDA Approves Novartis' ALK Inhibitor! Maybe...Really Soon?
The Street 04/11 11:07 ET

Someone at Novartis screwed up today by sending out a mass email announcing the FDA approval of a new lung cancer drug ceritinib. Brand name: Zykadia. The only problem is FDA hasn't announced the approval of Zykadia yet.

3 Stocks Pushing The Drugs Industry Downward
The Street 04/11 09:02 ET

TheStreet highlights 3 stocks pushing the drugs industry lower today.

{{article.title}} {{article.title}}
{{article.source}} {{article.time}}


Get News for

Recent Quotes

Symbol Price Chg Chg % Market Cap
NVS 84.67 +0.26 +0.31% 205.42B
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.